Impact of Clinical Pharmacist on the Quality and Cost of the Therapeutic Management of Patients in Two Medical Services of a Teaching Hospital (ImpactPharma)

Centre Hospitalier Universitaire de Nīmes

Status: Completed

Conditions: Admitted to Infectiology or Internal Medicine Wards

Treatments: Other: Pharmacist consultation

Study type: Interventional

Funder types: Other

Identifiers

NCT02887001

2010-A00186-35 (Other Identifier)

LOCAL/2010/JMK-01

Details and patient eligibility

About

Incomplete information or poorly communicated to the transitional stages of the patient's drug therapy hospitalized cause medication errors. These steps are the admission, transfer within the institution and hospital discharge to home or another institution.

The adequacy of the prescription recommendations of good practice is not always optimal.

The cost of taking drug therapy and iatrogenic risks preventable drug-related weighs more and more heavily in health spending and in the prolongation of hospitalization or re hospitalization.

Clinical pharmacy widely practiced in the Anglo-Saxon countries has demonstrated its effectiveness on these three themes; it seems appropriate to assess this practice in the environment of the French health system.

Enrollment: 500 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients admitted in in infectious and tropical diseases unit or the internal medicine unit

Exclusion criteria

• none

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

500 participants in 1 patient group

BMO

Other group

Treatment:

Other: Pharmacist consultation